Stocks · Health care · Biological Products, (No Diagnostic Substances)

HALOZYME THERAPEUTICS, INC.

HALO Clue Score50
United States Fiscal year ends December CIK 0001159036 Results filed 5 Nov 2026

What the insiders did Scheduled selling only

Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$48.10M
$3.45M on a plan · $44.65M straight out of an exercise
Sold at will
$0.00
0 of 105 sales
Net
−$48.10M
$0.00 against sales at will